Abstract:The functional and structural changes in the proximal tubule play an important role in the occurrence and development of diabetic kidney disease (DKD). Diabetes-induced metabolic changes, including lipid metabolism reprogramming, are reported to lead to changes in the state of tubular epithelial cells (TECs), and among all the disturbances in metabolism, mitochondria serve as central regulators. Mitochondrial dysfunction, accompanied by increased production of mitochondrial reactive oxygen species (mtROS), is considered one of the primary factors causing diabetic tubular injury. Most studies have discussed how altered metabolic flux drives mitochondrial oxidative stress during DKD. In the present study, we focused on targeting mitochondrial damage as an upstream factor in metabolic abnormalities under diabetic conditions in TECs. Using SS31, a tetrapeptide that protects the mitochondrial cristae structure, we demonstrated that mitochondrial oxidative damage contributes to TEC injury and lipid peroxidation caused by lipid accumulation. Mitochondria protected using SS31 significantly reversed the decreased expression of key enzymes and regulators of fatty acid oxidation (FAO), but had no obvious effect on major glucose metabolic rate-limiting enzymes. Mitochondrial oxidative stress facilitated renal Sphingosine-1-phosphate (S1P) deposition and SS31 limited the elevated Acer1, S1pr1 and SPHK1 activity, and the decreased Spns2 expression. These data suggest a role of mitochondrial oxidative damage in unbalanced lipid metabolism, including lipid droplet (LD) formulation, lipid peroxidation, and impaired FAO and sphingolipid homeostasis in DKD. An in vitro study demonstrated that high glucose drove elevated expression of cytosolic phospholipase A2 (cPLA2), which, in turn, was responsible for the altered lipid metabolism, including LD generation and S1P accumulation, in HK-2 cells. A mitochondria-targeted antioxidant inhibited the activation of cPLA2f isoforms. Taken together, these findings identify mechanistic links between mitochondrial oxidative metabolism and reprogrammed lipid metabolism in diabetic TECs, and provide further evidence for the nephroprotective effects of SS31 via influencing metabolic pathways.

Mitochondrial Dysfunction Accounts for Aldosterone-Induced Epithelial-to-mesenchymal Transition of Renal Proximal Tubular Epithelial Cells

Aldosterone Induces Epithelial-Mesenchymal Transition Via Ros of Mitochondrial Origin

Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage: A Therapeutic Target of PPARγ

Mitochondrial Dysfunction is an Early Event in Aldosterone-Induced Podocyte Injury

Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo

PGC-1α Overexpression Protects Against Aldosterone-Induced Podocyte Depletion: Role of Mitochondria

Activation of Peroxisome Proliferator-Activated Receptor-Γ Coactivator 1α Ameliorates Mitochondrial Dysfunction and Protects Podocytes from Aldosterone-Induced Injury.

Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway

Mitochondrial Reactive Oxygen Species-Mediated NLRP3 Inflammasome Activation Contributes to Aldosterone-Induced Renal Tubular Cells Injury.

P53/drp1-Dependent Mitochondrial Fission Mediates Aldosterone-Induced Podocyte Injury and Mitochondrial Dysfunction.

Mir-196B-5p-enriched Extracellular Vesicles from Tubular Epithelial Cells Mediated Aldosterone-Induced Renal Fibrosis in Mice with Diabetes

Aldosterone induces mesangial cell proliferation via PI3K-Akt-mTOR-p70S6K1 activation

Dysfunction of the PGC-1α-mitochondria Axis Confers Adriamycin-Induced Podocyte Injury.

Aldosterone suppresses cardiac mitochondria

Mitochondrial Derived Reactive Oxygen Species Mediates Aldosterone-Induced Epidermal Growth Factor Receptor Activation and Mesangial Cell Proliferation

SIRT3 Prevents Angiotensin II-induced Renal Tubular Epithelial-Mesenchymal Transition by Ameliorating Oxidative Stress and Mitochondrial Dysfunction.

The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone/mineralocorticoid receptor-induced podocyte injury

Angiotensin-Converting Enzyme-Dependent Intrarenal Angiotensin II Contributes to CTP: Phosphoethanolamine Cytidylyltransferase Downregulation, Mitochondrial Membranous Disruption, and Reactive Oxygen Species Overgeneration in Diabetic Tubulopathy

Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury

Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney

Esaxerenone Attenuates Aldosterone-Induced Mitochondrial Damage-Mediated Pyroptosis in Mouse Aorta and Rat Vascular Smooth Muscle Cells